The Effect of Women's Heart Health Awareness Program

March 25, 2026 updated by: Nurbanu Odacı, Lokman Hekim University

The Effect of a Heart Health Awareness Program on Women's Knowledge, Attitudes, and Practice Toward Cardiovascular Disease and Health Literacy: A Single-Blind Cluster Randomized Controlled Trial

The aim of this study is to examine the effect of a gender-specific heart health protection awareness program, incorporating video-supported reminder messages, on knowledge, attitudes, practices (KAP) regarding cardiovascular diseases and health literacy among adult women aged 20 to 64 with no prior diagnosis of cardiovascular disease. The centers where the study is conducted will be divided into intervention (n=4) and control (n=5) groups using cluster randomization. While the intervention group receives a heart health awareness program consisting of three sessions in total, including education, risk factor screening, and individual counseling over a period of three weeks, the control group will receive standard of care. Data will be collected at the beginning of the first session and after the completion of the final session.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

207

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being female,
  • Aged between 20 and 64 years (inclusive),
  • Being literate,
  • Regularly attending any course at the Family Center,
  • Active user of the WhatsApp application.

Exclusion Criteria:

  • Being an immigrant with a Turkish language barrier (unable to communicate in Turkish),
  • Being pregnant,
  • Being in the postpartum period,
  • Having a prior diagnosis of any cardiovascular disease,
  • Having a prior diagnosis of any type of cancer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Participants in the control group will not receive any intervention during the study and will continue to receive standard services. Data from this group will be collected concurrently with the intervention group at baseline and at the end of the 3rd week. For ethical reasons, following the collection of post-test data, educational brochures will be provided, and a screening session along with brief individual counseling will be conducted for the control group participants.
Experimental: Intervention Group
Participants will receive a heart health awareness program including education on cardiovascular disease prevention, risk factor screening, and brief individual counseling. Pre-test measurements will be taken before the intervention, and post-tests will be administered upon completion of the final session.
Behavioral: Heart Health Awareness Program
Intervention group participants will receive a 3-week program focused on cardiovascular diseases prevention, consisting of 45-minute weekly sessions. The first two sessions are educational sessions involving visual presentations, Q&A, and discussions, with informative brochures provided. To reinforce learning, six reminder video messages will be sent via WhatsApp every two days post-educational sessions. The final session includes a CVD risk screening (height, weight, BMI, waist circumference, blood pressure, and blood glucose) followed by brief individual counseling. Interventions will be conducted simultaneously across all sites by specially trained nurses. Pre-test measurements will be taken before the intervention, and post-tests will be administered upon completion of the final session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in knowledge sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention.
Time Frame: Baseline (Week 0) and at the end of the 3-week intervention period
The knowledge sub-dimension of the scale consists of 12 items designed to assess individuals' knowledge levels regarding cardiovascular disease risk factors and symptoms. Each item is scored as 0, 1, or 2, with total sub-dimension scores ranging from a minimum of 0 to a maximum of 24.
Baseline (Week 0) and at the end of the 3-week intervention period
Change in attitude sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention
Time Frame: Baseline (Week 0) and at the end of the 3-week intervention period
The attitude sub-dimension of the scale consists of 10 items designed to assess individuals' attitudes toward cardiovascular diseases. It utilizes a 5-point Likert-type scale, with total scores ranging from a minimum of 10 to a maximum of 50.
Baseline (Week 0) and at the end of the 3-week intervention period
Change in physical activity behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention
Time Frame: Baseline (Week 0) and at the end of the 3-week intervention period
The physical activity practices sub-dimension of the scale consists of two items assessing individuals' practices regarding cardiovascular disease risk factors. These items are scored using a 3-point rating scale (0-2).
Baseline (Week 0) and at the end of the 3-week intervention period
Change in diet and smoking behavior behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention
Time Frame: Baseline (Week 0) and at the end of the 3-week intervention period
The diet and smoking practices sub-dimension of the scale consists of five items assessing individuals' practices regarding cardiovascular disease risk factors. These items are scored using a 3-point rating scale (0-2).
Baseline (Week 0) and at the end of the 3-week intervention period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health Literacy Scale-Short Form scores from baseline to post-intervention
Time Frame: Baseline (Week 0) and at the end of the 3-week intervention period
The scale consists of 12 items and is scored using a 4-point Likert-type scale (ranging from 1 to 4). The index value is calculated using the formula Index = (Mean - 1) X 50 / 3, resulting in a score between 0 and 50. A higher score represents better health literacy.
Baseline (Week 0) and at the end of the 3-week intervention period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lokman Hekim University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 6, 2026

Primary Completion (Estimated)

April 20, 2026

Study Completion (Estimated)

April 20, 2026

Study Registration Dates

First Submitted

March 25, 2026

First Submitted That Met QC Criteria

March 25, 2026

First Posted (Actual)

March 31, 2026

Study Record Updates

Last Update Posted (Actual)

March 31, 2026

Last Update Submitted That Met QC Criteria

March 25, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LokmanHekimU-Hem-NO-03

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be broadly shared to ensure participant confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Risk Factors

Clinical Trials on Heart Health Awareness Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe